Kusajili – Clinical trials directory

Result of your search per sponsor: amel mezlini, professor

Woman Max 99 years
amel mezlini, professor Update Il y a 4 ans

Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer Multi-center, non randomised, open label, non controlled pilot study. Evaluating the treatment of bevacizumab in association with pre-operative chemotherapy, followed by surgery, adjuvant ...

Country Tunisia
organs None
Specialty None

unknown

More information